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Objectives: Arrhythmia is of concern after cardiac stem cells (CSCs) transplantation
in repairing infarcted myocardium. However, whether transplanted CSCs improved
ventricular ﬁbrillation threshold (VFT) in the myocardial infarction model is still
unclear. We sought to investigate the VFT in rats with myocardial infarction treated
with cardiac stem cells.
Methods: Myocardial infarction was induced by ligation of the left anterior des-
cending artery in 60 rats. 2 weeks later, animals were randomized to receive of 5106
CSCs labeled with PKH26 in phosphate buffer solution (PBS) (30 rats) or PBS
(30 rats) alone injection into the infarction zone in the anterior ventricular free wall. 2,
6 and 12 weeks after CSCs or PBS injection, VFT was measured on infarct zone,
infarct marginal zone and non-infarct zone (each period for 10 rats in CSCs group and
10 rats in PBS group). Labeled CSCs were observed in 5 mm cryostat sections from
each harvested heart.
Results: In the CSCs group, there were signiﬁcant improvements in VFT on the infarct
zone, infarct marginal zone and non-infarct zone compared with the PBS groups in
short-term (infarct zone: 10.22.4mA vs 3.70.9mA, infarct marginal zone:
8.91.9mA vs 3.61.6mA, non-infarct zone: 7.82.2mA vs 2.30.7mA. P<0.05)
and medium-term period (infarct zone: 8.43.0mA vs 4.01.6mA, infarct marginal
zone: 6.42.5mA vs 2.50.8mA, non-infarct zone: 7.02.6mA vs 3.41.0mA.
P<0.05). However, in long-term period, VFT was improved only on non-infarct zone
(6.52.0mA vs 3.51.4mA. P<0.05). Labeled CSCs were identiﬁed on infarct zone
and infarct marginal zone, and expressed Connexin-43 and a-sarcomeric actin.
Conclusions: The CSCs transplantation can improve the VFT in rats with myocardial
infarction in the short-term and medium-term period. However, as time goes on, the
improvement may be attenuate. The CSCs can differentiate into cardiomyocytes on
infarct zone and infarct marginal zone.
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Objectives: The objectives of this study were to determine the distribution of CD51-
positive (CD51+) cells in normal heart tissue in C57 mice, to culture and expand them
in vitro, and to verify their proliferation and differentiation potential. We thus hoped to
provide experimental evidence of CD51 as a marker of cardiac-derivedstem cells.
Methods: We used RT-PCR and Q-PCR to observe the expression levels of CD51+
cells in neonatal 1-day-(1d), 7-day-(7d), 1-month-(1m), and 3-month-old (3m) C57
mouse hearts. The distribution of CD51+ cells in 1d and 3m C57 mouse heart tissue
was detected by immunoﬂuorescence staining. The proliferation and multi-differen-
tiation capacity of CD51+ cells were tested by CCK-8 analysis and osteogenic and
adipogenic induction analyses, respectively. Finally, we tested the differentiation
potential of cardiomyocytes and smooth muscle cells by induction experiments after
cell passage to P6 and brieﬂy analyzed the induction efﬁciency.
Results: Expression levels of CD51+ cells were almost identical among mice of the
same age, and the levels declined with age. CD51+ cells were widely expressed in the
atria and ventricles of 7d C57 mice. We also found that the expression levels
decreased markedly in 3m C57 mouse heart tissue; only a few CD51+ cells remained
in the same locations in the atria and ventricles. Flow cytometry showed that the
positive rate was approximately 4.6% in 7d C57 mice, suggesting sufﬁcient quantities
of cells for vitro culture. We also obtained CD51+ cells by FACS from the hearts of 7d
C57 mice and found that these cells could proliferate with adherence status in serum-
free medium. Their morphology was similar to that of bone marrow MSCs. We
proved that besides differentiating into adipocytes and osteoblasts, these cells could
also differentiate into smooth muscle cells and cardiomyocytes in vitro after cell
passage yielded stable cell lines. Compared with bone marrow-derived MSCs, these
cells were found to exhibit low efﬁciency of differentiation into adipogenic and
osteogenic lines but high efﬁciency of differentiation into cardiomyocytes and smooth
muscle cells (about 10-15% respectively). On testing proliferation ability when the
cells extended to P5, P15, and P25, we found that the proliferation capacity had no
obvious difference, and proliferation continued.
Conclusions: CD51+ cells in murine myocardial tissue are cell subsets with stem cell
characteristics similar to those of MSC-like stem cells in the heart. Their proliferation
and differentiation potentials are similar to those of traditional bone marrow MSCs,
but they also possess their own biological characteristics. These differences can be
attributed to the original microenvironment of the heart. Thus, cardiac-derived MSC-
like stem cells might possess repair mechanisms different from those of MSCs derived
from bone marrow or other tissues. Furthermore, these cells may be more beneﬁcial in
the treatment heart disease in particular. The underlying mechanisms are not clear,
warranting further research to provide a new theoretical basis for exploring effective
stem cell therapy for heart disease.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BGW25-e0600
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Objectives: Endothium-denpendent vasodilation is impaired in vascular restenosis,
even before the development of atherosclerosis. The purpose of this study was to
determine whether infusion of angiotensin-(1-7), a biological active member of the
renin-angiotensin pepetide family, improves endothelium-dependent vasodilation in
rabbits with balloon injury.
Methods: Tweenty-four New Zealand white rabbits underwent sham surgery or an-
gioplasty in abdominal aorta. The animals were divided into 3 groups, which were
sham, control, ANG-(1-7). Subsequently, an osmotic minipump was implanted to
deliver saline, ANG-(1-7) (576mg$kg-1$d-1) for 4 weeks. After 4 weeks, abdominal
angiography was done through the left femoral, and then the diameter of the lumen
was calculated. After angiography, rabbits were killed for histological analysis,
immunohistochemistry analysis of Protein TGF-b1 and westernblot analysis of protein
Smad2.
Results: All rabbits with vascular injury showed that the abdominal aortic ﬂow was
signiﬁcantly increased after balloon dilation, and decreased 4 weeks after restenosis.
After vascular injury for 4 weeks, control group has signiﬁcantly decreased luman
diameter than sham group [(2.880.08) mm vs (3.850.03) mm, P<0.05]. ANG-(1-7)
group has signiﬁcantly increased luman diameter than control group [(4.110.10) mm
vs (2.880.08) mm, P<0.05]. Compared to control group, ANG-(1-7) group neointima
signiﬁcantly decreased thickness, neointimal area and restenosis rate [(207.5116.70)
mmvs (448.0815.30) mm, P<0.05; (2.660.09) mm2vs (4.080.02) mm2, P<0.05;
(28.132.74) % vs (40.132.74) %, P¼0.008, respectively]. But no difference was
found between sham group and ANG-(1-7) group. The expressive level of TGF-b1 in
control group was signiﬁcantly higher than ANG-(1-7) group (2.370.03 vs
1.460.02, P<0.05). The expressive level of TGF-b1 in injury vessel was positively
correlated with the restenosis rate (r¼0.73, P<0.001). The expressive levels of Smad2
were 6.96-fold and 2.69-fold in control group and ANG-(1-7) -treated group compared
to sham group 4 weeks after balloon injury.
Conclusions: ANG-(1-7) attenuates vascular restenosis and improves endothelium-
dependent vasodilation in rabbits with balloon injury. The mechanism was associated
with TGF-b_1/Smad Signaling Pathway.
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Objectives: To evaluate whether Wnt4/Dvl-1/ß-catenin signalling pathway modulates
balloon-injuried artery restenosis and try to ﬁnd potential therapeutic gene target of
anti-vascular restenosis.
Methods: Cell experiment in vitro: Cultured vascular smooth muscle cells (VSMC)
were stimulated by AngII (10-6mol/L). SiRNA-dvl-1 was employed to silence gene of
dvl-1. Atrovastatin of different concentration (0.1mmol/L, 1mmol/L, 10mmol/L) were
also enrolled in the cultured system. The SMCs proliferation was determined by MTT
assay. Several Wnt genes and proteins such as Wnt4, dvl-1, ß-catenin were quantitated
separatedly by Real-Time quantitative-PCR and Western blot assay. Animal experi-
ment in vivo: Rat model of balloon-injured carotid artery was established. SD rats
were randomized into 3 groups: sham operation group, operation group, atrovastatin
group. Ligated carotid arteries were removed 6 weeks after balloon injuried and to
assess intimal lesion size by HE staining. Immunohistochemistry was performed on rat
carotid artery to test Wnt4, dvl-1, ß-catenin.
Results: In vitro: (1) VSMC proliferation induced by AngII could be inhibited by
atrovastatin in a concentrated-dependent manner and siRNA-Dvl-1 (P<0.05). (2)
High expression of wnt signals (wnt4, dvl-1, ß-catenin) mRNA and proteins induced
by AngII could be down-regulated signiﬁcantly by atrovastatin with certain concen-
tration that inhibit SMC proliferation (P<0.05). (3) High expression of collegan I,
collegan III’s mRNA and proteins could be down-regulated signiﬁcantly by ator-
vastatin and siRNA-Dvl-1 (P<0.05). In vivo, compared with model group, (1)
hyperplasia of artery intima, area of neointimal, thickness of intima and area ratio of
intima/ tunica media in atrovastatin group were all reduced (P<0.05); (2) immuno-
histochemistry and western blot showed expression of wnt signals as Wnt4, dvl-1 and
ß -catenin in injured artery of atrovastatin group were reduced (P<0.05); (3) collagen
volume fraction by collagen speciﬁc staining with Picric Sirius red and proteins
expression of col1, 3 in injured artery by western blot reduced signiﬁcantly in atro-
vastatin group (P<0.05).
Conclusions: (1) wnt4/dvl-1/ß-catenin signalling pathway modulates proliferation of
smooth muscle cells from rats aorta induced by AngII; (2) Atrovastatin could inhibit
balloon-injured carotid artery restenosis by down-regulating wnt signalling pathway.
Wnt signalling pathway may become a novel potential therapeutic gene target of anti-
vascular restenosis.asic and Translational Medicine C5
